Company Overview of StemPath, Inc.
StemPath, Inc. develops therapeutic solutions for modulating body’s natural regenerative capacity and endogenously replacing damaged tissues with new tissues by intervention with small molecule and biological drugs. It develops peptide-based pharmaceuticals to stimulate heart and skeletal muscle regeneration. It offers cardiac and skeletal muscle myopathies. The company was founded in 2002 and is based in Ottawa, Canada.
501 Smyth Road
Ottawa, ON K1H 8L6
Founded in 2002
Key Executives for StemPath, Inc.
Similar Private Companies By Industry
|Resolution Pharmaceuticals Inc.||Americas|
|Planteck Biotechnologies Inc.||Americas|
|Receptor Therapeutics Inc.||Americas|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact StemPath, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.